Cannabis Law Report

JULY 30, 2021

The FDA is currently in an ongoing process evaluating the science and safety of CBD and hemp derivatives in order to determine potential regulatory pathways for hemp. Regulatory Oversight of Hemp and Cannabis. The FDA already has primary regulatory authority over all hemp and hemp derivatives.

Hemp 105

Hemp Law Seed-To-Sale Food 105

Cannabis Law Report

JULY 1, 2021

Mason Marks: The project’s goal is to promote safety, innovation, equity, and accessibility in emerging psychedelics industries. Things have changed a little in the past twenty years, when the DEA gave some researchers permission to study limited amounts of certain psychedelics. POPLAR will publish original law and policy research.

Law 81

Law Research and Development Therapy DEA 81

Veriheal

AUGUST 31, 2020

and farmers are required to have their crops tested at various labs registered with the Drug Enforcement Administration (DEA), but there are not enough labs to meet the demand for testing. . Supply chains are disrupted as a result, and consumers grow fearful of buying hemp. Personal data and information would be anonymous.

Research and Development 119

Research and Development Education Agriculture Patients 119

Cannabis Law Report

MAY 24, 2022

Facts and Procedural History: The Controlled Substances Act was passed in 1970 and created a single legal framework for regulating substances that are thought to have a high risk of abuse and addiction. Substances considered to pose the greatest risk to the public health and safety are subject to the most stringent controls and sanctions.

DEA 52

DEA History Medicine Marijuana 52

Cannabis Law Report

MAY 25, 2022

The court also considered Boyd Street’s counterarguments that (1) DEA has interpreted the 2018 Farm Bill as inapplicable to delta-8 THC due to its method of manufacture and (2) Congress never intended for the Act to legalize any psychoactive substance. as opposed to delta-8 THC or total THC (i.e.,

THC 52

THC Legalization Hemp Concentrates 52

Cannabis Law Report

APRIL 24, 2019

Such actions by the federal will create some very difficult paths because of policy distinctions arising from individual rights, public protections, commercial activities, health and safety, use of resources, etc.]. Will the mandate for the DEA be changed to oversee another special agricultural legal crop or a medicine ?

Legalization 58

Legalization Collective DEA Banking 58

Cannabis Law Report

JUNE 15, 2021

Prohibits the denial of employment or termination based upon a criminal history for drug possession. Charges HHS with establishing a “Commission on Substance Use, Health and Safety,” to determine the benchmark amounts for drug possession and publish an online report on their findings within 180 days.

Decriminalization 60

Decriminalization Policy Research and Development Data 60

SpeedWeed

AUGUST 19, 2021

And now that delta-8 THC , its trendy cousin, has been outlawed in some states across the country and flagged by the DEA , THC-O’s star may rise even faster. . While THC-O products like vape carts and tinctures are available for purchase online, both their legal status and their safety remain unproven. .

THC 40

THC Hemp Extraction Vaping 40

SpeedWeed

MARCH 18, 2021

They also wrote: The study sample included participants with a history of cannabis use. Wasn’t the DEA going to let others grow research-grade cannabis? In fact, nearly half of the veterans who received a placebo believed they had been given active cannabis. It tested at only 9% THC. Bruce Kennedy.

Clinical Trials 40

Clinical Trials THC Strains Cannabis 40

Cannabis Law Report

APRIL 14, 2022

Similar issues arise under state and federal employee safety and worker Right-to-Know laws, as employees must be educated on the chemicals present and proper handling and risk management procedures. pursuant to Drug Enforcement Agency (DEA) or state-level programs).

Environment 52

Environment Agriculture Compliance Compliance 52

Cannabis Law Report

NOVEMBER 2, 2021

Testing for Safety: Are Impurities a Problem? Testing for Safety: Are Impurities a Problem? As in this case, this also happened relatively early in the history of e-cigarettes, when the industry had much less oversight and there were undoubtedly many companies who cared more about cashing in than their customers.

THC 96

THC CBD Legalization Vaping 96

Cannabis Law Report

MAY 1, 2019

For a business which has decided to publish ads for cannabis businesses, there are a number of steps that would minimize the risk of receiving a call from a federal prosecutor or a visit from your local DEA agent. See Medicinal and Adult-Use Cannabis Regulation and Safety Act, Cal. FOOTNOTES. & Prof. Code § 26032. 2 Ajax Letter.

Legalization 45

Legalization Business Law Cannabis 45

SpeedWeed

MARCH 7, 2021

Is it cost savings, increased sales, less waste, safety, all the above? And now the DEA just recently poked their head into that too, so I think there’s a lot of question marks for both cultivators and processors with respect to hemp. ‍ Mark Diener : Pretty much all of the above. That’s gotten huge.

Extraction 52

Extraction Data Hemp Research and Development 52

Canna Law Blog

OCTOBER 1, 2020

This post examines the history of religious exemptions to the CSA. According to the CSA (and subsequent regulations ), Schedule I substances have a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision. DEA Interim Guidelines.

History 98

History Law DEA Safety 98

Cannabis Law Report

JULY 9, 2021

Drug Enforcement Agency (“DEA”). Some physicians and therapists have argued that the Right to Try Act permits them to administer psilocybin to terminally ill patients (since studies are well past the Phase 1 stage), but the DEA has met this with resistance given psilocybin’s status as a Schedule I drug. AIMS Institute, PLLC.

Law 81

Law Therapy Clinical Trials Research and Development 81

Cannabis Law Report

APRIL 8, 2022

To celebrate this, we invite you to take a trip down memory lane and review highlights from every year of our history. Later that year, Doblin sued the DEA for the first time. MAPS completed the first Phase 1 safety study with MDMA and resumed working on a protocol for anxiety associated with cancer. Rick Doblin, Ph.D.,

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

SEPTEMBER 23, 2019

Therefore, the AAFP advocates for further research into the overall safety and health effects of recreational use, as well as the effects of those laws on patient and societal health. The AAFP supports requirements testing current marijuana and cannabinoid products for safety, dosing, and product consistency. In the Exam Room.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

The Cannigma

JULY 3, 2023

They found that it could be used in sessions to promote trust and safety, helping patients to open up and process traumatic experiences. 12 From a safety perspective, there are concerns about mixing drugs increasing chances of addiction across the board, and of course unpredictable, and potentially dangerous impairment.

Research and Development 46

Research and Development Environment THC Microdosing 46

The Cannigma

SEPTEMBER 12, 2021

The safety of using these products however, is still unknown. Marijuana (defined in the US as any cannabis plant where THC>0.3%) is a schedule I drug according to the DEA and FDA. The first researcher who identified and isolated THC, was the American Roger Adams (Shutterstock). Who discovered THC?

THC 98

THC Research and Development Cannabinoids CBD 98

Cannabis Law Report

FEBRUARY 28, 2022

Patents on psychedelics raise unique concerns associated with their unusual qualities, history, and regulation. Controlled Substance Schedules , DRUG ENF’T ADMIN., [link] [ [link] ] (defining DEA criteria for categorization in Schedule I and listing psychedelic examples such as lysergic acid diethylamide (LSD), peyote, and MDMA).

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Cannabis Law Report

AUGUST 6, 2021

Drug Enforcement Administration (the “DEA”), the U.S. state and federal law to U.S. hemp (including CBD) products and the scope of any regulations by the U.S. Food and Drug Administration (the “FDA”), the U.S. Federal Trade Commission (the “FTC”), the U.S. Patent and Trademark Office (the “USPTO”), the U.S. hemp industry in the U.S.,

Vaping 105

Vaping Research and Development Data Business 105

Cannabis Law Report

JUNE 1, 2021

Drug Enforcement Administration (the “DEA”), the U.S. state and federal law to U.S. hemp (including CBD) products and the scope of any regulations by the U.S. Food and Drug Administration (the “FDA”), the U.S. Federal Trade Commission (the “FTC”), the U.S. hemp industry in the U.S.,

Data 95

Data Vaping Supply Chain Business 95

Cannabis Law Report

SEPTEMBER 19, 2019

Here are three of the most pressing matters that might give Congress absolutely no choice but to surrender to marijuana legalization in the interest of public health and safety. . . “ It is already causing a slew of problems in states across the nation. Reason #1: Police confused on how to distinguish the difference between?

Vaping 55

Vaping Hemp Education Patients 55

Puff Puff Post

NOVEMBER 11, 2019

In order to fully understand how drug scheduling works, it’s important to understand some of the history behind it, including the rationale for why the system was created in the first place. Following his announcement of a new “war on drugs” in 1971, Richard Nixon created the Drug Enforcement Administration (DEA) in 1973. Schedule 1.

DEA 53

DEA History Legislation Banking 53

Cannabis Law Report

JULY 14, 2021

These efforts are not mutually exclusive, and history has shown that when it comes to cannabis, every step in the right direction builds momentum for bigger and better reforms at the state and national level.”. Additionally, revenue generated by federal taxes will support restorative justice and public health and safety research.

Legislation 71

Legislation Banking History Access 71

Cannabis Law Report

SEPTEMBER 29, 2021

Many producers expressed concerns that the DEA’s interim final rule would criminalize the processing of hemp extracts. The bill would also get rid of the USDA’s requirement that only DEA laboratories can test hemp products. There are currently zero DEA registered labs in my home state and [only] one in New England,” Pingree said.

Hemp 52

Hemp Banking Legislation Policy 52